Overview
Paul Celano is an Oncologist practicing medicine in Baltimore, Maryland.
Dr. Celano is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Ovarian Cancer, Testicular Yolk Sac Tumor, Ovarian Carcinosarcoma, and Virilizing Ovarian Tumor.
He is actively involved in clinical research, co-authoring 21 peer reviewed articles and participating in 12 clinical trials.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
6569 N Charles St Ste 201, Baltimore, MD 21204
6535 N Charles St Ste 220, Towson, MD 21204
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
12 Clinical Trials
Office
Taofeek Owonikoko is a Hematologist and an Oncologist practicing medicine in Baltimore, Maryland. Dr. Owonikoko is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Tissue Biopsy.
Skip Viragh Outpatient Cancer Center
Dr. Matthias Holdhoff is a medical oncologist and co-director of the Brain Cancer Disease Group at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. He is a professor of oncology, neurology and neurological surgery at Johns Hopkins University School of Medicine. Dr. Holdhoff’s expertise is in primary brain cancers and central nervous system lymphomas. He earned his medical degree from Freie Universität Berlin, received his doctorate degree at Charité University Medicine Berlin. Dr. Holdhoff completed residency training in internal medicine at Johns Hopkins Bayview Medical Center, followed by a fellowship in medical oncology at Johns Hopkins Hospital with research training at the Ludwig Center for Cancer Genetics and Therapeutics (Kinzler-Vogelstein lab). As a clinical investigator in neuro-oncology, his research is focused on novel trials and translational biomarker studies in malignant gliomas and primary central nervous system lymphomas. He has led and contributed to numerous clinical trials, publications and presentations. Dr. Holdhoff serves as the director of the solid tumor inpatient service at the Sidney Kimmel Comprehensive Cancer Center. He is passionately involved in mentoring and teaching of fellows, residents and students. He is the director of the UCNS-certified neuro-oncology fellowship program at Johns Hopkins, and he is a teaching attending physician for the Osler internal medicine residency program. Dr. Holdhoff is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Glioma, Glioblastoma, Astrocytoma, and Brain Tumor. Dr. Holdhoff is board certified in American Board Of Internal Medicine.
Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville
Nirmish Singla is an Oncologist practicing medicine in Lutherville, Maryland. Dr. Singla is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Upper Tract Urothelial Carcinoma (UTUC), Renal Cell Carcinoma (RCC), Urothelial Cancer, Nephrectomy, and Orchiectomy. Dr. Singla is board certified in American Board Of Urology.
Frequently Asked Questions about Dr. Paul Celano
How do I make an appointment with Dr. Paul Celano?
You can book an appointment with Dr. Paul Celano by calling their office at 443-849-3051. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Paul Celano a top-rated expert for Ovarian Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Paul Celano is classified as an Distinguished expert for Ovarian Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Paul Celano specialize in?
While Dr. Paul Celano is a Oncology, they have specific expertise in Ovarian Cancer, Testicular Yolk Sac Tumor, and Ovarian Carcinosarcoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Paul Celano participate in research or clinical trials?
Yes. Dr. Paul Celano has published 21 articles and abstracts on conditions like Ovarian Cancer. You can view a list of Dr. Paul Celano's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Paul Celano accept my insurance?
Dr. Paul Celano accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 443-849-3051 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chronic Lymphocytic Leukemia (CLL)Dr. Celano isDistinguished. Learn about Chronic Lymphocytic Leukemia (CLL).
- Endometrial CancerDr. Celano isDistinguished. Learn about Endometrial Cancer.
- Large-Cell Immunoblastic LymphomaDr. Celano isDistinguished. Learn about Large-Cell Immunoblastic Lymphoma.
- Ovarian CancerDr. Celano isDistinguished. Learn about Ovarian Cancer.
- Ovarian CarcinosarcomaDr. Celano isDistinguished. Learn about Ovarian Carcinosarcoma.
- Paget Disease of the BreastDr. Celano isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- Adult Soft Tissue SarcomaDr. Celano isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- Breast CancerDr. Celano isAdvanced. Learn about Breast Cancer.
- Chronic B-Cell Leukemia (CBCL)Dr. Celano isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Colorectal CancerDr. Celano isAdvanced. Learn about Colorectal Cancer.
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Essential ThrombocythemiaDr. Celano isAdvanced. Learn about Essential Thrombocythemia.
- Experienced
- Adrenal CancerDr. Celano isExperienced. Learn about Adrenal Cancer.
- Adrenocortical CarcinomaDr. Celano isExperienced. Learn about Adrenocortical Carcinoma.
- Adult Immune ThrombocytopeniaDr. Celano isExperienced. Learn about Adult Immune Thrombocytopenia.
- ALK-Positive Non-Small Cell Lung CancerDr. Celano isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Anal CancerDr. Celano isExperienced. Learn about Anal Cancer.
- AngiosarcomaDr. Celano isExperienced. Learn about Angiosarcoma.

